Add BrightSurf on Google Email

Study could lead to new treatments for neuroblastoma

Researchers have identified a new potential treatment for neuroblastoma by targeting the ALT mechanism, which is responsible for chemotherapy resistance. The study found that activating ATM kinase at telomeres promotes chemotherapy resistance in ALT neuroblastoma and suggests a cancer-specific approach to treating this disease.

SourceTexas Tech University Health Sciences Center·JournalScience Translational Medicine·TypeExperimental study·DateAug 23, 2021

Detect with PKAchu

Biologists developed fluorescent mice to visualize protein kinase A (PKA) activation in the retina. They found that light stimulation activates PKA for nearly 15 minutes in rod cells, which are essential for night vision.

A mechanism capable of preserving muscle mass

Researchers identify protein CaVbeta1E that promotes muscle mass maintenance via GDF5 signaling, counteracting sarcopenia. The study opens a new field of activity in developing therapeutic strategies against muscular decline associated with aging.

SourceAFM-Téléthon·JournalScience Translational Medicine·DateNov 6, 2019

Manufacture of light-activated proteins

A new strategy for designing light-sensitive proteins has been developed by researchers at Ruhr-Universität Bochum. They combined computer-aided and experimental methods to create a more targeted approach, enabling the manipulation of protein building blocks without impairing function.

SourceRuhr-University Bochum·JournalChemBioChem·DateAug 2, 2019

Novel mechanism of immune activation in HIV-exposed, seronegative people who inject drugs

Researchers at The Wistar Institute found that the S100A14 protein is expressed at higher levels in these individuals than control donors, activating natural killer cells to defend against HIV. This discovery may lead to novel approaches for prevention of HIV infection by manipulating host immune defense.

SourceThe Wistar Institute·JournalJAIDS Journal of Acquired Immune Deficiency Syndromes·DateNov 13, 2018

E. coli infection induces delirium in aging rats

Research reveals that E. coli infection can induce delirium in aging rats by reducing levels of brain-derived neurotrophic factor (BDNF), a protein essential for long-term memory formation. The study suggests that immune system activation, such as after surgery or infection, may contribute to cognitive decline in the elderly.

SourceSociety for Neuroscience·JournaleNeuro·DateMay 29, 2018

Computer model showed an optimal anti-amyloid treatment

A computer model developed by InSysBio scientists suggests that activating beta-amyloid degradation is key to preventing protein plaques in the brain. The model found that starting treatment at age 60 can lead to relative normalization of indices, highlighting the importance of early intervention.

SourceInSysBio LLC·JournalCPT Pharmacometrics & Systems Pharmacology·DateSep 28, 2017